New Leaf Venture Partners, L.L.C. has filed its 13F form on November 13, 2024 for Q3 2024 where it was disclosed a total value porftolio of $96.9 Million distributed in 10 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Edgewise Therapeutics, Inc. with a value of $41.5M, Arvinas, Inc. with a value of $35.3M, Crinetics Pharmaceuticals, Inc. with a value of $7.2M, Rallybio Corp with a value of $3.86M, and Rocket Pharmaceuticals, Inc. with a value of $2.78M.

Examining the 13F form we can see an increase of $14.8M in the current position value, from $82.1M to 96.9M.

New Leaf Venture Partners, L.L.C. is based out at New York, NY

Below you can find more details about New Leaf Venture Partners, L.L.C. portfolio as well as his latest detailed transactions.

Portfolio value $96.9 Million
Healthcare: $96.9 Million

Stock Holdings Table Market Cap. of $300 Millions to $2 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 10
  • Current Value $96.9 Million
  • Prior Value $82.1 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 13, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 0 stocks
  • Additional Purchases 2 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track New Leaf Venture Partners, L.L.C. Portfolio

Follow New Leaf Venture Partners, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Leaf Venture Partners, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on New Leaf Venture Partners, L.L.C. with notifications on news.